Neuromodulation Approach to Systemic PCOS Disorder

Polycystic Ovary Syndrome (PCOS) is a neuroendocrine-metabolic network disorder affecting 1 in 8 women globally. Historically misunderstood, it stems from neuroendocrine and metabolic disruptions impacting brain signaling, reproductive health, and systemic conditions like insulin resistance. Current treatments focus on symptom management through hormonal contraceptives and lifestyle changes, though root causes remain unaddressed. Advancements include innovative devices targeting the...